Ethylene oxide sensitivity in hemodialysis patients

Area of Science:

• Immunology
• Nephrology
• Toxicology

Background:

• Hypersensitivity-type reactions are a concern for patients undergoing hemodialysis.
• Ethylene oxide (ETO) is a sterilant used for medical devices, including dialyzers.

Purpose of the Study:

• To investigate the role of ethylene oxide (ETO) hypersensitivity in hemodialysis-associated reactions.
• To determine if specific IgE antibodies to ETO are elevated in hemodialysis patients experiencing adverse reactions.

Main Methods:

• Retrospective radioallergosorbent test (RAST) analysis of sera from 138 hemodialysis patients with reactions and 78 controls.
• Utilized human serum albumin conjugated to ETO (HSA-ETO) and dialyzer rinse fluid extract as antigens in RAST assays.
• Performed RAST inhibition studies using HSA-ETO and dialyzer extract.

Main Results:

• Elevated serum RAST values for IgE antibodies to ETO were significantly more common in reactors (63%) compared to controls (11%, p < 0.001).
• RAST assays using HSA-ETO and dialyzer extract yielded similar results (correlation coefficient = 0.829, p < 0.001).
• RAST inhibition confirmed antigenicity of both HSA-ETO and dialyzer extract.

Conclusions:

• Specific IgE antibodies to ethylene oxide are frequently found in hemodialysis patients experiencing hypersensitivity reactions.
• These findings support the hypothesis that ethylene oxide hypersensitivity is a significant factor in hemodialysis-associated adverse reactions.
• Further research is warranted to confirm the clinical implications of ETO sensitivity in this patient population.